This Lung Cancer Awareness Month find out more about one of the most common cancers in the UK population and how CCL can support with the diagnosis and treatment pathway.
Read More
This Breast Cancer Awareness Month find out more about the most common cancer in the UK population and how CCL can support with the diagnosis and treatment pathway.
Read More
CCL is now running the Oncimmune EarlyCDT Lung test. The EarlyCDT Lung test is a simple finger prick blood test which results can indicate whether an individual has an increased risk of lung cancer.
Read More
This Bowel Cancer Awareness month, Cambridge Clinical Laboratories is announcing that it is opening up the availability of the FIT test (Faecal Immunochemical Test) to all.
Read More
Cambridge Clinical Laboratories launches our new suite of tests to support the UK prostate cancer pathway.
Read More
Cambridge Clinical Laboratories (CCL) announces today, Friday 27 August, that CCL will be the UK partner for Prostatype Genomics in bringing the Prostatype® prostate cancer gene test to the UK market.
Read More
A focus on Bladder Cancer - what it is, a snapshot of Bladder Cancer in the UK, and a summary of the tests available at Cambridge Clinical Laboratories.
Read More
A focus on Covid-19 - what it is, a snapshot of Covid-19 in the UK and the impact on our National Health Service, and a summary of the tests available at Cambridge Clinical Laboratories.
Read More
A focus on Prostate Cancer - what it is, a snapshot of Prostate Cancer in the UK, and a summary of the tests available at Cambridge Clinical Laboratories.
Read More
The Select MDx test that we run at Cambridge Clinical Laboratories is now available through BMI Healthcare. The test is a non-invasive urine test to improve patient selection for prostate cancer diagnostic biopsy and therefore will alleviate many from going through the invasive biopsy.
Read More